There are piles of close to zero cost options and early issued shares that are tradeable - management primarily, I think. I presume that is what is occurring.
But as far as the company goes, I don’t see why it can’t say how the trials are going structurally - ie, has Covid disrupted things, is it going to delay results, is there anything else going on etc? Something. Anything. It’s just crickets otherwise.
There are piles of close to zero cost options and early issued...
Add EBR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
95.0¢ |
Change
0.005(0.53%) |
Mkt cap ! $291.1M | |||
| Open | High | Low | Value | Volume |
| 94.5¢ | 95.0¢ | 94.5¢ | $12.86K | 13.58K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2500 | 93.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 95.0¢ | 26352 | 4 |
View Market Depth
| Last trade - 11.36am 29/04/2024 (20 minute delay) ? |
|
|||||
|
Last
97.0¢ |
Change
0.005 ( 7.55 %) |
||||
| Open | High | Low | Volume | ||
| 94.5¢ | 97.0¢ | 94.5¢ | 11009 | ||
| Last updated 12.09pm 29/04/2024 ? | |||||
| EBR (ASX) Chart |